IMPORTANCE Identifying infectious causes of subacute or chronic meningitis can be challenging. Enhanced, unbiased diagnostic approaches are needed.
S ubacute and chronic meningitis are diagnostically challenging given the wide range of potential infectious, autoimmune, neoplastic, paraneoplastic, parameningeal, and toxic causes.
1,2 Securing a final diagnosis can require weeks or months of testing or remain unsolved, necessitating empirical treatment approaches that may be ineffective or even harmful. Unlike traditional testing for specific microbes or categories of infection, metagenomic next-generation sequencing (mNGS) of cerebrospinal fluid (CSF) or brain tissue screens for nearly all potential central nervous system (CNS) infections and can identify novel or unexpected pathogens. [3] [4] [5] [6] [7] [8] [9] [10] Multiple computational algorithms and pipelines have been developed to rapidly identify microbial sequences in mNGS data sets. [11] [12] [13] However, mNGS data require careful analysis to determine which, if any, of the identified microbes represent a true pathogen rather than environmental contamination. Failure to make this distinction has resulted in spurious disease associations with organisms later determined to be laboratory contaminants. [14] [15] [16] In the present study, we developed a straightforward statistical approach to analyze mNGS data, leveraging an extensive mNGS database of water-only control samples (n = 24) and surplus CSF samples (n = 94) obtained from patients with clinically adjudicated noninfectious neurologic diagnoses, including autoimmune, neoplastic, structural, and neurodegenerative disorders (a control cohort). This statistical approach quantified the uniqueness of observing a particular microbe in a patient sample at a given level of abundance by comparison with its mean level of abundance across the control cohort. We report herein the utility of this statistical framework for identifying microbial pathogens in 7 challenging cases of subacute or chronic meningitis as well as for analyzing publicly available data from recent mNGS infectious diagnostic and brain microbiota studies.
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Methods
Participants were recruited between September 2013 and March 2017 as part of a larger study applying mNGS to biological samples from patients with suspected neuroinflammatory disease. The 7 participants enrolled in the present study had subacute or chronic leptomeningitis with or without encephalitis. An etiologic diagnosis was not known by the researchers at the time of study enrollment. If a diagnosis was made by traditional means before mNGS testing was completed (participants 3, 5, and 6), the researchers performing mNGS (M.R.W. and J.L.D.) remained blinded to the diagnosis. The patients were referred from the UCSF (University of California, San Francisco) Medical Center (n = 2), Zuckerberg San Francisco General Hospital (n = 2), Cleveland Clinic (n = 1), University of Washington (n = 1), and Kaiser Permanente (n = 1). The UCSF Institutional Review Board approved the study protocol, and participants or their surrogates provided written informed consent. Treating physicians were informed about research-based mNGS results through a reporting mechanism approved by the UCSF Institutional Review Board.
mNGS Protocol
Metagenomic next-generation sequencing was performed on total RNA extracted from surplus CSF (250-500 μL), and 1 participant also had mNGS performed on total RNA extracted from snap frozen surplus tissue (<50 mg) obtained from a lumbar meningeal biopsy. Samples were processed for mNGS as previously described. 5, 7 The nonhuman sequence reads from each sample were deposited at the National Center for Biotechnology Information Sequence Read Archive (PRJNA338853).
Bioinformatics Analysis
Paired-end sequences of 125 to 150 base pairs were analyzed using a previously described rapid computational pathogen detection pipeline consisting of open-source components ( Figure 1) . 5, 7, [20] [21] [22] [23] [24] [25] [26] Unique nonhuman sequences were assigned to microbial taxonomic identifiers based on nucleotide (nt) and nonredundant (nr) protein alignments. To distinguish putative pathogens from contaminating microbial sequences derived from skin, collection tubes, laboratory reagents, or the environment, a composite background model of metagenomic data was used. This model incorporated 24 water control samples and 94 CSF samples from patients with noninfectious diagnoses, including 21 patients with chronic meningitis with or without encephalitis. Data were normalized to unique reads mapped per million (RPM) input reads for each microbe at the species and genus level.
Statistical Analysis
Using the aforementioned background data set as the expected mean RPM for a given taxonomic identifier, standard z scores were calculated for each genus (gs) and species (sp) in each sample based on the results from both the nt and nr database searches. Thus, there are 4 z scores reported for each sample: spznt, gsznt, spznr, and gsznr. To prioritize reporting of the most unique (ie, unexpected) taxa in each sample, the significance of each microbial species was mapped to a single value with the following empirically derived formula:
Here, RPM is scaled by the z scores for both the species and the genus. If both z scores were negative, the product remained negative. The maximum z score was arbitrarily capped
Key Points
Question How can metagenomic next-generation sequencing of cerebrospinal fluid be leveraged to aid in the diagnosis of patients with subacute or chronic meningitis?
Findings In this case series, metagenomic next-generation sequencing identified a parasitic worm, a virus, and 4 fungi among 7 participants with subacute or chronic meningitis. A database generated using water-only and healthy patient control samples enabled application of a z score-based scoring algorithm to effectively separate bona fide pathogen sequences from spurious environmental sequences.
Meaning
The scoring algorithm greatly simplified data interpretation among patients with a wide range of challenging infectious causes of subacute or chronic meningitis identified by metagenomic next-generation sequencing.
at 100. This product was calculated for alignments to both the nt and nr databases and summed. The top-ranked taxa were considered with respect to the clinical features of the participant. Microbes with known CNS pathogenicity that could cause a clinical phenotype concordant with the clinical presentation were considered potential pathogens and were confirmed using standard microbiologic assays, as described in the brief case histories presented below.
Results
The age of the 7 study participants ranged from 10 to 55 years, and 3 participants (43%) were female. Additional clinical characteristics are given in Table 1 . In each case, the causative pathogen was found within the top 2 scoring microbes identified by our algorithm (Figure 2 ). Across the 7 study participants, the mean of the reported taxa was reduced by 87% (range, 41%-99%) when taxa with a combined score of zero or less were removed (mean before filtering: 307 [range, taxa; after filtering: 53 [range 1-297 taxa]).
Case Descriptions
Taenia solium Participant 1 was a 28-year-old man from Central America with headache and diplopia. An examination of his CSF revealed an opening pressure greater than 50 cm, white blood cell (WBC) count of 66/μL comprising 89% lymphocytes, 4% neutrophils, 4% monocytes, and 3% eosinophils (to convert to a proportion, multiply by 0.01), red blood cell (RBC) count of 1/μL, total protein level of 43 mg/dL (reference range, 15-50 mg/dL; to convert to grams per liter, multiply by 0.01), and glucose level of 27 mg/dL (reference range, 40-70 mg/dL; to convert to millimoles per liter, multiply by 0.0555). Contrastenhanced brain magnetic resonance imaging (MRI) revealed enhancement of the basilar meninges and several cranial nerves ( Figure 3A) . Although the serum cysticercosis antibody test result was positive, there were no cysts or calcifications detected on brain MRI. The low CSF glucose level, basilar meningitis, positive tuberculin skin test, positive tuberculosis interferon-gamma release assay, and high-risk region of origin prompted empirical treatment of Mycobacterium tuberculosis (TB) meningitis. The patient improved clinically during the next 3 weeks but then worsened, requiring multiple lumbar punctures (LPs), MRIs, and hospitalizations during the next year. Subsequent CSF samples showed worsening lymphocytic pleocytosis and persistently low glucose and elevated protein levels. Neuroimaging results showed persistent basilar meningitis and development of communicating hydrocephalus, again without cysts. His incomplete clinical response was initially attributed to noncompliance with medical treatment, but after he worsened despite directly observed TB therapy, multidrug-resistant TB was suspected. His fourth clinical decline included worsening hydrocephalus and discussion of ventriculoperitoneal shunt placement. He was readmitted to the hospital for new diagnostic tests. Empirical therapy was broadened to include antihelminthic treatment. His CSF was submitted for research-based mNGS. The mNGS data indicated no sequences aligning to mycobacterial species. However, 58 789 unique, nonhuman read-pairs aligned to the genus Taenia ( Table 2) , with the vast majority specifically mapping to the T solium genome ( Figure 2) . A CSF specimen that had been sent concurrently for fungal 18s ribosomal RNA (rRNA) polymerase chain reaction (PCR) unexpectedly amplified the T solium 18s rRNA gene, and the result of a CSF cysticercosis IgG antibody test was positive. A fast imaging protocol employing a steady-state acquisition sequence was included for the first time on the brain MRI, and the results revealed tangled hypointensities in the basilar cisterns, most prominently involving the prepontine cistern with extension into the right side internal auditory canal. After 8 months of antihelminthic treatment, he clinically improved to baseline except for a residual action tremor. Participant 2 was a 34-year-old woman who had immigrated to the United States from Central America 13 years earlier. She presented with 9 months of right-sided headache, leftsided facial numbness, right-sided pulsatile tinnitus, and recurrent loss of consciousness. Brain MRI showed hydrocephalus and right anterior temporal lobe and prepontine cysts ( Figure 3B ). Her CSF examination revealed an opening pressure of 36 cm, a WBC count of 115/μL comprising 1% neutrophils, 31% monocytes, 46% lymphocytes, 21% plasmacytoid lymphocytes, and 1% eosinophils, a RBC count of 2/μL, a glucose level of less than 10 mg/dL, and a total protein level of 89 mg/dL. After her CSF and serum cysticercosis IgG antibody test results returned positive, she was treated with albendazole and prednisone for more than 1 month. However, she developed worsening neck pain, and a repeated CSF examination showed elevated intracranial pressure, pleocytosis with a new eosinophilia, an undetectable glucose level, and an elevated total protein level, raising concern for an alternative diagnosis. Her CSF mNGS data contained 569 read-pairs (Table 2) aligning to the genus Taenia (Figure 2 ). She was treated with dual antihelminthic therapy and adjunctive glucocorticoids and had an excellent clinical response.
Cryptococcus neoformans
Participant 3 was a 52-year-old man with a history of migraine and an HIV-1 infection diagnosed in 2013 (viral load detectable but <40 copies/mL; CD4 count 20 cells/μL). He also Strip plot of normalized species significance scores for microbial taxa (colored circles) in each participant sample (row). In 6 of 7 samples, the neurologic infection (orange circles) is ranked as the most significant by our approach. In participant number 5, Aspergillus oryzae is ranked second behind GB virus C, a likely concurrent infection unassociated with the clinical presentation (blue circle). Microbes likely representing environmental contaminants are also shown (gray circles). mNGS (Figure 2 ) or by standard diagnostic assays. He clinically improved on additional treatment with anticryptococcal therapy.
Recurrent Encephalopathy With Known HIV-1 Infection
Participant 4 was a 55-year-old man with a treatment-naive HIV-1 infection that had been diagnosed 8 years earlier. He presented to the emergency department with 2 weeks of confusion and decreased verbal output as well as with several months of cough, intermittent night sweats, and weight loss; his CD4 count was 6 cells/μL. A brain MRI showed bilateral confluent nonenhancing white matter T2 hyperintensities. A CSF examination showed that both his WBC and RBC counts were 0/μL, his glucose level was 34 mg/dL, and his total protein level was 93 mg/dL. Cerebrospinal fluid mNGS testing revealed more than 136 000 unique read-pairs aligning to HIV-1 ( Table 2 , Figure 2 ). The full-length HIV-1 genome was assembled using the paired read iterative contig extension assembler, version 1. Figure 2 ). After 2 months of treatment, she could ambulate but continued to have profound left hearing loss, facial weakness, and neurogenic bladder.
Candida dubliniensis
Participant 7 was a 26-year-old woman with an initially undisclosed history of injection drug use who presented with 1 year of atraumatic lower back pain followed by subacute development of saddle anesthesia and left foot drop. Her MRI results indicated a loculated rim-enhancing collection extending from the top of the lumbar spine anteriorly, compressing the conus medullaris against the posterior wall, in addition to diffuse leptomeningitis involving the entire spinal cord and brainstem ( Figure 3C-E) . Cisternal CSF showed a WBC count of 126/μL comprising 67% neutrophils, 22% lymphocytes, and 11% monocytes, an RBC count of 4/μL, a total protein level of 105 mg/dL, and a glucose level of 40 mg/dL. Extensive infectious disease diagnostic studies were unrevealing, and 11 weeks later the patient underwent lumbar meningeal biopsy. The pathology findings revealed noninflammatory dense fibrous tissue, and no microbes were identified. Consistent with the pathology results showing no evidence of active infection in the biopsy specimen, 18s rRNA and 16s rRNA PCR tests and mNGS of the biopsy specimen revealed no evidence of infection. In addition, 18s rRNA PCR test results of the CSF were also negative. Three months later, the patient required the use of a wheelchair. Repeated cisternal CSF showed a WBC count of 700/μL comprising 81% neutrophils, 16% lymphocytes, 2% monocytes, and 1% eosinophils, a RBC count of 2/μL, total protein level of 131 mg/dL, and a glucose level of 44 mg/dL. Cerebrospinal fluid mNGS revealed 68 read-pairs mapping to Candida species (Table 2) , with 61 of the 68 pairs mapping to Candida dubliniensis with 99% to 100% identity. The CSF (1,3) β-D-glucan assay result was 211 pg/mL (normal, <80 pg/mL), whereas the serum (1,3) β-D-glucan assay had repeatedly shown normal levels. Findings from repeated CSF 18s rRNA and 16s rRNA PCR assays were negative. The patient was treated with combination antifungal therapy and showed mild clinical improvement, normalization of her CSF profile [including an undetectable CSF (1,3) β-D-glucan level], and decreasing leptomeningeal enhancement on MRI. Of the 3 previously reported patients who have received a diagnosis of C dubliniensis meningitis, 2 patients had a history of injection drug use.
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Reagent and Environmental Contaminant Background Signatures
Examination of nucleotide alignments generated by nontemplated water-only control samples (n = 24) and noninfectious CSF samples (n = 94) revealed 4400 unique bacterial, viral, and eukaryotic genera (eTable in Supplement 1). This microbial background signature was dominated (>70%) by consistent proportions of bacterial taxa, primarily the Proteobacteria and Actinobacteria phyla (eFigure1AandBinSupplement 2) representing common soil, skin, and environmental flora previously reported as laboratory and reagent contaminants. 16 To determine if these common microbial contaminants may have been misclassified as pathogens in previously published studies, we examined publicly available data from 2 cases of meningoencephalitis for which a possible infection was identified by mNGS. 19 In each case, neither organism (Delftia acidovorans or Elizabethkingia) was present at levels significantly greater than the mean of our background data set of water-only and noninfectious CSF control samples (eFigure 1C in Supplement 2). We then examined data from 2 studies aiming to characterize the "brain microbiome" and correlate brain dysbiosis to disease. 17, 18 The abundance of the purported brain microbiota revealed distributions that were well within the observed variance of our set of background water-only nontemplated control samples (eFigure 1D in Supplement 2). The authors of the brain microbiome studies 17,18 did not deep sequence water controls when they were unable to generate measurable quantities of DNA after reverse transcription-PCR. The presence of environmental contaminants is due in part to low amounts of input RNA, which is frequently the case with acellular CSF samples, combined with the high number of PCR amplification cycles necessary to generate a sequencing library. To assess this explicitly, we performed an RNA doping experiment (eFigure 2 in Supplement 2) on a water sample and an uninfected CSF sample from which there was no detectable complementary DNA after reverse transcription-PCR. The mNGS library generated from the water had 9.4% unique nonhuman sequences, and that from the CSF sample had 7.6% unique nonhuman sequences. The proportion of nonhuman sequences markedly dropped after spiking with only 20 pg of RNA of a known identity, suggesting that nonhuman environmental sequences are particularly problematic for low input nucleic acid samples, which is often the case for CSF.
Discussion
We presented 7 diagnostically challenging cases of subacute or chronic meningitis in which the use of mNGS of CSF identified a pathogen, including a case of subarachnoid neurocysticercosis that had defied diagnosis for 1 year, the first reported case of CNS vasculitis caused by A oryzae, and the fourth reported case of C dubliniensis meningitis. A straightforward statistical model leveraging a large mNGS data set obtained from water-only nontemplated control samples and from patients with a variety of noninfectious neuroinflammatory syndromes correctly prioritized the pathogens. Larger prospective studies are needed to determine the clinical utility of this approach for reducing the number of false-positives and falsenegatives. The use of CSF mNGS has the potential to overcome several limitations of conventional CNS infectious disease diagnostics. First, the inherent risks of brain or meningeal biopsy make CSF mNGS a particularly attractive and less invasive diagnostic option for patients with suspected CNS infection. Second, the large number of neuroinvasive pathogens that cause subacute or chronic meningitis makes it logistically challenging and cost prohibitive to order every possible neuroinfectious diagnostic test using a candidate-based approach. Third, some assays lack sensitivity in the context of impaired immunity or acute infection (eg, West Nile virus serology), can be slow to yield results (eg, mycobacterial and fungal cultures), or may fail to differentiate between active infection and prior exposure (eg, cysticercosis antibody or interferongamma release assay for TB).
The unbiased nature of mNGS makes the data sets inherently polymicrobial and complex. Thus, statistical scoring and filtering is essential to enhance the ability to discriminate between insignificant contaminants and true infectious organisms. Our algorithm correctly prioritized etiologic pathogens among these 7 clinically confirmed cases of infectious meningitis despite the pathogens ranging widely in absolute abundance (33-136 000 sequence read-pairs) and in the proportion of the nonhuman sequences (0.9%-92.7%) that they comprised (Table 2) .
We also analyzed a recently published clinical mNGS data set 19 to highlight that a thorough profile of the microbes present in water-only control and noninfectious CSF samples reinforces the skepticism with which those authors described a possible infection of 1 participant with Delftia acidovorans (patient 2) and of another participant with Elizabethkingia (patient 7) (eFigure 1C in Supplement 2). Furthermore, such a database could help improve the accuracy of microbiome studies, especially for body sites historically considered sterile in which rigorous controls are necessary to establish that observed microbial sequences represent microbiota vs environmental contaminants (eFigure 1D in Supplement 2). 18, 19 This problem appears to be particularly critical in samples, such as those from the CSF, in which subnanogram levels of input RNA or DNA require unbiased molecular amplification steps before sufficient material is available for sequencing applications. Indeed, the addition of only 20 pg of purified RNA to a CSF sample was sufficient to suppress the majority of nonhuman reads derived from the water and reagents (eFigure 2 in Supplement 2). Although amplifying the input signal increases the sensitivity of the assay, it also often overrepre-sents the signature of contaminating taxa unique to a given laboratory, experimenter, or reagent lot. 14, 16 These results provide a cautionary note and underscore the need for appropriate controls to aid in interpretation.
Limitations
We expect that larger databases of patient mNGS results will only enhance the ability to discriminate between irrelevant sequences and legitimate pathogens and permit more rigorous and probabilistic models for pathogen ranking and reporting. We presented herein 1 empirically derived system for prioritizing results based on the read count weighted by standard z scores. Given the sensitivity of NGS-based approaches, we anticipate that individual laboratories will need to develop their own dynamic reference data sets to control for contaminants that are relevant to the particular time, place, and manner in which the biological samples are being analyzed.
Conclusions
Metagenomic next-generation sequencing represents an increasingly rapid and comparatively low-cost means of screening CSF in an unbiased manner for a broad range of human pathogens using a single diagnostic test. Although the present selected case series is not appropriate to measure the performance characteristics in a prospective cohort, a recently completed demonstration project sponsored by the state of California 30 may also prove to be helpful in supporting the exclusion of CNS infection when a coinfection is suspected in an immunosuppressed patient (as illustrated with C neoformans and HIV-1) or when a noninfectious cause, such as an autoimmune condition, is clinically favored. On this basis, we foresee the eventual replacement of many single-agent assays performed in reference laboratories with a unified mNGS approach. 
